Our Research

Showing all translational research programs

Experimental Therapeutics

Group Leader : Prof Michelle Haber AM
This program aims to identify ‘molecular targets’ - critical genes and proteins that contribute to the growth and malignant behaviour of cancer cells, so that therapeutic strategies can then be developed to inhibit their action, with the goal of treating the cancer more effectively ...
Michelle Haber

Leukaemia Biology

Group Leader : Prof Richard Lock
The long-term goal of the Leukaemia Biology program is to improve the treatment of children with leukaemia through the development of new therapies and their preclinical testing in clinically relevant experimental models ...
Richard Lock

Molecular Carcinogenesis

Group Leader : Prof Glenn Marshall
The Molecular Carcinogenesis program aims to improve our understanding of the molecules and processes that initiate childhood cancer as currently very little is known about the factors that lead to the development of cancer in children ...
Glenn Marshall

Molecular Diagnostics

Group Leader : Prof Murray Norris
The Molecular Diagnostics program uses molecular genetics techniques to improve the diagnosis and risk classification of childhood cancers including leukaemia and neuroblastoma ...
Murray Norris

Back to top